A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.

@article{Xu2014APM,
  title={A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.},
  author={Bo Xu and Run-lin Gao and Jian'an Wang and Yuejin Yang and Shaoliang Chen and Bin Liu and Fang Chen and Zhanquan Li and Yaling Han and Guosheng Fu and Yelin Zhao and Junbo Ge},
  journal={JACC. Cardiovascular interventions},
  year={2014},
  volume={7 2},
  pages={
          204-211
        }
}
OBJECTIVES The intention of the PEPCAD China ISR (A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated versus Paclitaxel-Eluting Stent for the Treatment of Drug-Eluting Stent In-Stent Restenosis) was to demonstrate the efficacy of paclitaxel-coated balloon (PCB) angioplasty in a non-European patient population with coronary drug-eluting stent in-stent restenosis (DES-ISR). BACKGROUND The treatment of DES-ISR is still challenging with no established best strategy. Moreover, there… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 40 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 18 REFERENCES

Similar Papers

Loading similar papers…